BamSEC and AlphaSense Join Forces
Learn More

Cyclacel Pharmaceuticals Inc.

NASDAQ: CYCC    
Share price (12/24/24): $0.32    
Market cap (12/24/24): $1.997 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 12 pages Holder of Warrants Issued in May 2024 Re: Inducement Offer to Exercise Warrants Issued in May 2024 Dear Holder
12/34/56
EX-10.1
from 8-K 16 pages 2018 Equity Incentive Plan, as Amended Effective June 21, 2024
12/34/56
EX-10.2
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.15
from S-1/A 18 pages Cyclacel Pharmaceuticals, Inc. and Equiniti Trust Company, LLC as Warrant Agent Warrant Agency Agreement Dated as of , 2024 Warrant Agency Agreement
12/34/56
EX-10.14
from S-1/A 40 pages Securities Purchase Agreement
12/34/56
EX-10.13
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.3
from 8-K 16 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 16 pages Placement Agency Agreement December 21, 2023
12/34/56
EX-10.16
from 10-K/A 8 pages Indemnification Agreement
12/34/56
EX-10.1
from 8-K 16 pages 2018 Equity Incentive Plan, as Amended Effective June 13, 2023
12/34/56
EX-10.2
from 8-K 22 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.16
from 10-K 8 pages Indemnification Agreement
12/34/56
EX-10.2
from 8-K 1 page Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights, Nj 07922 December 28, 2022
12/34/56
EX-10.1
from 8-K 1 page Cyclacel Pharmaceuticals, Inc. 200 Connell Drive, Suite 1500 Berkeley Heights, Nj 07922 December 28, 2022
12/34/56
EX-10.1
from 8-K 16 pages 2018 Equity Incentive Plan, as Amended Effective June 14, 2022
12/34/56
EX-10.2
from 8-K/A 19 pages Employment Agreement
12/34/56
EX-10.1
from 8-K/A 14 pages Employment Agreement
12/34/56